MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹2,177 Cr | ₹1,852 Cr | ₹1,491 Cr | ₹1,376 Cr | ₹1,134 Cr |
What is the latest Revenue of MARKSANS PHARMA ?
Year | Revenue |
---|---|
Mar2024 | ₹2,177 Cr |
Mar2023 | ₹1,852 Cr |
Mar2022 | ₹1,491 Cr |
Mar2021 | ₹1,376 Cr |
Mar2020 | ₹1,134 Cr |
How is Revenue of MARKSANS PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹2,177 Cr | 17.56 | |
Mar2023 | ₹1,852 Cr | 24.23 | |
Mar2022 | ₹1,491 Cr | 8.33 | |
Mar2021 | ₹1,376 Cr | 21.33 | |
Mar2020 | ₹1,134 Cr | - |
Compare Revenue of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,459.2 Cr | -2.8% | -13.4% | 59.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹437,135.0 Cr | 2.7% | 0.9% | 34.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,074.0 Cr | -1.1% | 1.1% | 57.7% | Stock Analytics | |
CIPLA | ₹114,019.0 Cr | 0.6% | -1.7% | 8.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,192.0 Cr | -1.6% | -4.6% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,256.3 Cr | -0.5% | 2.5% | 36% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -2.8% |
-13.4% |
59.8% |
SENSEX | -0.6% |
-2.9% |
6.3% |
You may also like the below Video Courses